 |
 |
 |
|
FOSTEMSAVIR EXPOSURE-RESPONSE RELATIONSHIPS IN TREATMENT EXPERIENCED HIV PATIENTS
|
|
|
CROI 2020 March 8-11
Reported by Jules Levin
Ridhi Parasrampuria,1Navin Goyal,1Katy Moore,2Peter Ackerman,3Cyril C. Llamoso,3Keith Barker,4Mindy Magee1
1GlaxoSmithKline, Collegeville, PA, USA; 2ViiV Healthcare, Research Triangle Park, NC, USA; 3ViiV Healthcare, Branford, CT, USA; 4GlaxoSmithKline, Uxbridge, UK






|
|
|
 |
 |
|
|